Paracrine Factors in Tubuloglomerular Feedback: Adenosine, ATP, and Nitric Oxide

Annual Review of Physiology

Volumn 65, Issue , 2003, Pages 501-529

  Schnermann, Jürgen ^a   Levine, David Z ^b  

^a NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES   (United States)

^b OTTAWA HOSPITAL RESEARCH INSTITUTE   (Canada)

Author keywords

5 nucleotidase; Cyclic AMP; Diabetes mellitus; Purinoceptors; Superoxide

Indexed keywords

ADENOSINE RECEPTOR; ADENOSINE TRIPHOSPHATE; ANGIOTENSIN; CANCER GROWTH FACTOR; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; GUANINE NUCLEOTIDE BINDING PROTEIN; MESSENGER RNA; NUCLEOTIDE; PROTEIN DERIVATIVE; PURINE ANTAGONIST; PURINE P2X RECEPTOR; PURINE P2X1 RECEPTOR; PURINE P2Y RECEPTOR; RECEPTOR BLOCKING AGENT; SODIUM CHLORIDE; ADENOSINE; NITRIC OXIDE;

ARTERY CONSTRICTION; ARTERY TONE; BINDING AFFINITY; CELL FUNCTION; CONCENTRATION RESPONSE; DESENSITIZATION; DRUG EFFECT; ENZYME INHIBITION; EXTRACELLULAR SPACE; FEEDBACK SYSTEM; GLOMERULUS; HOMEOSTASIS; IN SITU HYBRIDIZATION; KIDNEY TUBULE; KNOCKOUT MOUSE; MACULA DENSA; MOLECULAR MECHANICS; NONHUMAN; PARACRINE SIGNALING; PATCH CLAMP; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN PROTEIN INTERACTION; PROTEIN SECRETION; REGULATORY MECHANISM; REVIEW; SENSORY NERVE; UNTRANSLATED REGION; VASOMOTOR REFLEX; ANIMAL; HUMAN; METABOLISM; PHYSIOLOGY;

ADENOSINE; ADENOSINE TRIPHOSPHATE; ANIMALS; FEEDBACK, BIOCHEMICAL; HUMANS; KIDNEY GLOMERULUS; KIDNEY TUBULES; NITRIC OXIDE; PARACRINE COMMUNICATION;

EID: 0037704152     PISSN: 00664278     EISSN: None     Source Type: Book Series    
DOI: 10.1146/annurev.physiol.65.050102.085738     Document Type: Review

References (161)

1. Gutierrez AM, Kornfeld M, Persson AEG. 1999. Calcium response to adenosine and ATP in rabbit afferent arterioles. Acta Physiol. Scand. 166:175-81
2. Weaver DR, Reppert SM. 1992. Adenosine receptor gene expression in rat kidney. Am. J. Physiol. Renal Physiol. 263:F991-F95
3. Kreisberg MS, Silldorff EP, Pallone TL. 1997. Localization of adenosine-receptor subtype mRNA in rat outer medullary descending vasa recta by RT-PCR. Am. J. Physiol. Heart Circ. Physiol. 272: H1231-H38
4. Yamaguchi S, Umemura S, Tamura K, Iwamoto T, Nyui N, et al. 1995. Adenosine A1 receptor mRNA in microdissected rat nephron segments. Hypertension 26:1181-85
5. 2a receptors on renal microvascular reactivity. Am. J. Physiol. Renal Physiol. 280:F406-F14
6. Weihprecht H, Lorenz JN, Briggs JP, Schnermann J. 1992. Vasomotor effects of purinergic agonists in isolated rabbit afferent arterioles. Am. J. Physiol. Renal Physiol. 263:F1026-F33
7. Joyner WL, Mohama RE, Myers TO, Gilmore JP. 1988. The selective response to adenosine of renal microvessels from hamster explants. Microvasc. Res. 35:122-31
8. Holz FG, Steinhausen M. 1987. Renovascular effects of adenosine receptor agonists. Renal Physiol. 10:272-82
9. Osswald H, Spielman WS, Knox FG. 1978. Mechanism of adenosine-mediated decreases in glomerular filtration rate in dogs. Circ. Res. 43:465-69
10. Dietrich MS, Endlich K, Parekh N, Steinhausen M. 1991. Interaction between adenosine and angiotensin II in renal microcirculation. Microvasc. Res. 41:275-88
11. Franco M, Bell PD, Navar LG. 1989. Effect of adenosine A1 analogue on tubuloglomerular feedback mechanism. Am. J. Physiol. Renal Physiol. 251:F231-F36
12. Schnermann J. 1988. Effect of adenosine analogues on tubuloglomerular feedback responses. Am. J. Physiol. Renal Physiol. 255:F33-F42
13. Schnermann J, Weihprecht H, Briggs JP. 1990. Inhibition of tubuloglomerular feedback during adenosinel receptor blockade. Am. J. Physiol. Renal Physiol. 258:F553-F61
14. Ren Y, Arima S, Carretero OA, Ito S. 2002. Possible role of adenosine in macula densa control of glomerular hemodynamics. Kidney Int. 61:169-76
15. Schnermann J, Osswald H, Hermle M. 1977. Inhibitory effect of methylxanthines on feedback control of glomerular filtration rate in the rat. Pflügers Arch. 369:39-48
16. Bell PD. 1985. Cyclic AMP-calcium interaction in the transmission of tubuloglomerular feedback signals. Kidney Int. 28:728-32
17. Osswald H, Hermes HH, Nabakowski G. 1982. Role of adenosine in signal transmission of tubuloglomerular feedback. Kidney Int. Suppl. 12:8136-42
18. Thomson S, Bao D, Deng A, Vallon V. 2000. Adenosine formed by 5′-nucleotidase mediates tubuloglomerular feedback. J. Clin. Invest. 106:289-98
19. Kawabata M, Ogawa T, Takabatake T. 1998. Control of rat glomerular microcirculation by juxtaglomerular adenosine A1 receptors. Kidney Int. Suppl. 67:8228-30
20. Wilcox CS, Welch WJ, Schreiner GF, Belardinelli L. 1999. Natriuretic and diuretic actions of a highly selective adenosine A1 receptor antagonist. J. Am. Soc. Nephrol. 10:714-20
21. Ren Y, Garvin JL, Carretero OA. 2001. Efferent arteriole tubuloglomerular feedback in the renal nephron. Kidney Int. 59:222-29
22. Premen AJ, Hall JE, Mizelle HL, Cornell JE. 1985. Maintenance of renal autoregulation during infusion of aminophylline or adenosine. Am. J. Physiol. Renal Physiol. 248:F366-F73
23. Ogawa N, Ono H. 1988. Modulation of cyclic AMP and autoregulation of renal blood flow, analysed by the use of forskolin and 1-methyl-3- isobutylxanthine. J. Pharm. Pharmacol. 40:207-9
24. Ibarrola AM, Inscho EW, Vari RC, Navar LG. 1991. Influence of adenosine receptor blockade on renal function and renal autoregulation. J. Am. Soc. Nephrol. 2:991-99
25. Thomson SC, Blantz RC. 1993. Homeostatic efficiency of tubuloglomerular feedback in hydropenia, euvolemia, and acute volume expansion. Am. J. Physiol. Renal Physiol. 264:F930-F36
26. 1 receptor. Proc. Natl. Acad. Sci. USA 98:9407-12
27. Sun D, Samuelson LC, Yang T, Huang Y, Paliege A, et al. 2001. Mediation of tubuloglomerular feedback by adenosine: evidence from mice lacking adenosine 1 receptors. Proc. Natl. Acad. Sci. USA 98:9983-88
28. Brown R, Ollerstam A, Johansson B, Skott O, Gebre-Medhin S, et al. 2001. Abolished tubuloglomerular feedback and increased plasma renin in adenosine A1 receptor-deficient mice. Am. J. Physiol. Regul. Integr. Comp. Physiol. 281: R1362-R67
29. Hall JE, Granger JP, Hester RL. 1985. Interactions between adenosine and angiotensin II in controlling glomerular filtration. Am. J. Physiol. Renal Physiol. 248:F340-F46
30. Hall JE, Granger JP. 1986. Adenosine alters glomerular filtration control by angiotensin II. Am. J. Physiol. Renal Physiol. 250:F917-F23
31. Weihprecht H, Lorenz JN, Briggs JP, Schnermann J. 1994. Synergistic effects of angiotensin and adenosine in the renal microvasculature. Am. J. Physiol. Renal Physiol. 266:F227-F39
32. Spielman WS, Osswald H. 1979. Blockade of postocclusive renal vasoconstriction by an angiotensin II antagonists: evidence for an angiotensin-adenosine interaction. Am. J. Physiol. Renal Physiol. 237:F463-F47
33. Traynor T, Yang T, Huang YG, Arend L, Oliverio MI, et al. 1998. Inhibition of adenosine-1 receptor-mediated preglomerular vasoconstriction in AT1A receptor-deficient mice. Am. J. Physiol. Renal Physiol. 275:F922-F27
34. Stowe N, Schnermann J, Hermle M. 1979. Feedback regulation of nephron filtration rate during pharmacologic interference with the renin-angiotensin and adrenergic systems in rats. Kidney Int. 15:473-86
35. Ploth DW, Rudulph J, LaGrange R, Navar LG. 1979. Tubuloglomerular feedback and single nephron function after converting enzyme inhibition in the rat. J. Clin. Invest. 64:1325-35
36. Schnermann J, Briggs JP. 1989. Single nephron comparison of the effect of loop of Henle flow on filtration rate and pressure in control and angiotensin II-infused rats. Miner. Electrolyte Metab. 15:103-7
37. Mitchell KD, Navar LG. 1988. Enhanced tubuloglomerular feedback during peritubular infusions of angiotensins I and II. Am. J. Physiol. Renal Physiol. 255:F383-F90
38. Schnermann JB, Traynor T, Yang T, Huang YG, Oliverio MI, et al. 1997. Absence of tubuloglomerular feedback responses in AT1A receptor-deficient mice. Am. J. Physiol. Renal Physiol. 273:F315-F20
39. Traynor T, Yang T, Huang YG, Krege JH, Briggs JP, et al. 1999. Tubuloglomerular feedback in ACE-deficient mice. Am. J. Physiol. Renal Physiol. 276: F751-F57
40. el-Etr M, Cordier J, Glowinski J, Premont J. 1989. A neuroglial cooperativity is required for the potentiation by 2-chloroadenosine of the muscarinic-sensitive phospholipase C in the striaturn. J. Neurosci. 9:1473-80
41. 2+ and insulin secretion. Biochem. J. 293:721-28
42. Biber K, Fiebich BL, Gebicke-Harter P, van Calker D. 1999. Carbamazepine-induced upregulation of adenosine Al-receptors in astrocyte cultures affects coupling to the phosphoinositol signaling pathway. Neuropsychopharmacology 20:271-78
43. Dickenson JM, Hill SJ. 1994. Interactions between adenosine A1- and histamine H1-receptors. Int. J. Biochem. 26:959-69
44. Dickenson JM, Hill SJ. 1996. Synergistic interactions between human transfected adenosine A1 receptors and endogenous cholecystokinin receptors in CHO cells. Eur. J. Pharmacol. 302:141-51
45. Megson AC, Dickenson JM, Town-send-Nicholson A, Hill SJ. 1995. Synergy between the inositol phosphate responses to transfected human adenosine A1-receptors and constitutive P2-purinoceptors in CHO-K1 cells. Br. J. Pharmacol. 115:1415-24
46. Okajima F, Tomura H, Sho K, Akbar M, Majid MA, et al. 1995. Intracellular cross-talk between thyrotropin receptor and A1 adenosine receptor in regulation of phospholipase C and adenylate cyclase in COS-7 cells transfected with their receptor genes. Biochem. J. 306: 709-15
47. Ashkenazi A, Winslow JW, Peralta EG, Peterson GL, Schimerlik MI, et al. 1987. An M2 muscarinic receptor subtype coupled to both adenylyl cyclase and phosphoinositide turnover. Science 238:672-75
48. Zhu X, Gilbert S, Birnbaumer M, Birnbaumer L. 1994. Dual signaling potential is common among Gs-coupled receptors and dependent on receptor density. Mol. Pharmacol. 46:460-69
49. Bimbaumer L. 1992. Receptor-to-effector signaling through Gproteins: roles for beta gamma dimers as well as alpha subunits. Cell 71:1069-72
50. Zhu X, Birnbaumer L. 1996. G protein subunits and the stimulation of phospholipase C by Gs- and Gi-coupled receptors: lack of receptor selectivity of Galpha(16) and evidence for a synergic interaction between Gbeta gamma and the alpha subunit of a receptor activated G protein. Proc. Natl. Acad. Sci. USA 93:2827-31
51. Biber K, Klotz KN, Berger M, Gebicke-Harter PJ, van Calker D. 1997. Adenosine A1 receptor-mediated activation of phospholipase C in cultured astrocytes depends on the level of receptor expression. J. Neurosci. 17:4956-64
52. Tomura H, Itoh H, Sho K, Sato K, Nagao M, et al. 1997. Betagamma subunits of pertussis toxin-sensitive G proteins mediate A1 adenosine receptor agonist-induced activation of phospholipase C in collaboration with thyrotropin. A novel stimulatory mechanism through the cross-talk of two types of receptors. J. Biol. Chem. 272:23130-37
53. Dickenson JM, Hill SJ. 1998. Involvement of G-protein betagamma subunits in coupling the adenosine A1 receptor to phospholipase C in transfected CHO cells. Eur. J. Pharmacol. 355:85-93
54. Quitterer U, Lohse MJ. 1999. Crosstalk between Galpha(i)- and Galpha(q)-coupled receptors is mediated by Gbeta-gamma exchange. Proc. Natl. Acad. Sci. USA 96:10626-31
55. Ralevic V, Burnstock G. 1998. Receptors for purines and pyrimidines. Pharmacol. Rev. 50:413-92
56. Chan CM, Unwin RJ, Bardini M, Oglesby IB, Ford AP, et al. 1998. Localization of P2X1 purinoceptors by autoradiography and immunohistochemistry in rat kidneys. Am. J. Physiol. Renal Physiol. 274:F799-804
57. Inscho EW, Ohishi K, Navar LG. 1992. Effects of ATP on pre- and post-glomerular juxtamedullary microvasculature. Am. J. Physiol. Renal Physiol. 263:F886-F93
58. 2-purinoceptor agonists. Am. J. Physiol. Renal Physiol. 274:F718-F27
59. Eltze M, Ullrich B. 1996. Characterization of vascular P2 purinoceptors in the rat isolated perfused kidney. Eur. J. Pharmacol. 306:139-52
60. Churchill PC, Ellis VR. 1993. Pharmacological characterization of the renovascular P2 purinergic receptors. J. Pharmacol. Exp. Ther. 265:334-38
61. Inscho EW, Ohishi K, Cook AK, Belott TP, Navar LG. 1995. Calcium activation mechanisms in the renal microvascular response to extracellular ATP. Am. J. Physiol. Renal Physiol. 268:F876-F84
62. Mitchell KD, Navar LG. 1993. Modulation of tubuloglomerular feedback responsiveness by extracellular ATP. Am. J. Physiol. Renal Physiol. 264:F458-F66
63. Inscho EW, Cook AK, Navar LG. 1996. Pressure-mediated vasoconstriction of juxtamedullary afferent arterioles involves P2-purinoceptor activation. Am. J. Physiol. Renal Physiol. 271:F1077-F85
64. Cha SH, Sekine T, Endou H. 1998. P2 purinoceptor localization along rat nephron and evidence suggesting existence of subtypes P2Y1 and P2Y2. Am. J. Physiol. Renal Physiol. 274:F1006-F14
65. Mulryan K, Gitterman DP, Lewis CJ, Vial C, Leckie BJ, et al. 2000. Reduced vas deferens contraction and male infertility in mice lacking P2X1 receptors. Nature 403:86-89
66. Majid DS, Inscho EW, Navar LG. 1999. P2 purinoceptor saturation by adenosine triphosphate impairs renal autoregulation in dogs. J. Am. Soc. Nephrol. 10:492-98
67. Milner P, Kirkpatrick KA, Ralevic V, Toothill V, Pearson J, et al. 1990. Endothelial cells cultured from human umbilical vein release ATP, substance P and acetylcholine in response to increased flow. Proc. R. Soc. London Ser. B 241: 245-48.
68. Bodin P, Burnstock G. 2001. Evidence that release of adenosine triphosphate from endothelial cells during increased shear stress is vesicular. J. Cardiovasc. Pharmacol. 38:900-8
69. Wang Y, Roman R, Lidofsky SD, Fitz JG. 1996. Autocrine signaling through ATP release represents a novel mechanism for cell volume regulation. Proc. Natl. Acad. Sci. USA 93:12020-25
70. Nishiyama A, Majid DS, Taher KA, Miyatake A, Navar LG. 2000. Relation between renal interstitial ATP concentrations and autoregulation-mediated changes in renal vascular resistance. Circ. Res. 86:656-62
71. Osswald H, Schmitz HJ, Kemper R. 1977. Tissue content of adenosine, inosine and hypoxanthine in the rat kidney after ischemia and postischemic recirculation. Pflügers Arch. 371:45-49
72. Nishiyama A, Kimura S, He H, Miura K, Rahman M, et al. 2001. Renal interstitial adenosine metabolism during ischemia in dogs. Am. J. Physiol. Renal Physiol. 280:F231-F38
73. Nishiyama A, Miura K, Miyatake A, Fujisawa Y, Yue W, et al. 1999. Renal interstitial concentration of adenosine during endotoxin shock. Eur. J. Pharmacol. 385:209-16
74. Zou AP, Nithipatikom K, Li PL, Cowley AW Jr. 1999. Role of renal medullary adenosine in the control of blood flow and sodium excretion. Am. J. Physiol. Renal Physiol. 276:R790-R98
75. Siragy HM, Linden J. 1996. Sodium intake markedly alters renal interstitial fluid adenosine. Hypertension 27:404-7
76. Baranowski RL, Westenfelder C. 1994. Estimation of renal interstitial adenosine and purine metabolites by microdialysis. Am. J. Physiol. Renal Physiol. 267:F174-F82
77. Sala-Newby GB, Newby AC. 2001. Cloning of a mouse cytosolic 5′-nucleotidase-I identifies a new gene related to human autoimmune infertility-related protein. Biochim. Biophys. Acta 1521:12-18
78. Hunsucker SA, Spychala J, Mitchell BS. 2001. Human cytosolic 5′-nucleotidase I: characterization and role in nucleoside analog resistance. J. Biol. Chem. 276:10498-504
79. Sala-Newby GB, Skladanowski AC, Newby AC. 1999. The mechanism of adenosine formation in cells. Cloning of cytosolic 5′-nucleotidase-I. J. Biol. Chem. 274:17789-93
80. Walker JP, Darvish A, Yeasting RA, Metting PJ. 1995. Localization of AMP-specific cytosolic 5′-nucleotidase in the kidney: regional sites of intracellular adenosine production. FASEB J. 9:A843 (Abstr.)
81. Cass CE, Young JD, Baldwin SA. 1998. Recent advances in the molecular biology of nucleoside transporters of mammalian cells. Biochem. Cell Biol. 76:761-70
82. Williams TC, Doherty AJ, Griffith DA, Jarvis SM. 1989. Characterization of sodium-dependent and sodium-independent nucleoside transport systems in rabbit brush-border and basolateral plasma-membrane vesicles from the renal outer cortex. Biochem. J. 264:223-31
83. Schwiebert EM, Kishore BK. 2001. Extracellular nucleotide signaling along the renal epithelium. Am. J. Physiol. Renal Physiol. 280:F945-F63
84. Bell P, Lapointe JY, Sabirov R, Hayashi S, Okada Y. 2000. Maxi-chloride channel in macula densa cells: possible pathway for ATP release. FASEB J. 14:A134 (Abstr.)
85. Hazama A, Hayashi S, Okada Y. 1998. Cell surface measurements of ATP release from single pancreatic beta cells using a novel biosensor technique. Pflügers Arch. 437:31-35
86. Sabirov RZ, Dutta AK, Okada Y. 2001. Volume-dependent ATP-conductive large-conductance anion channel as a pathway for swelling-induced ATP release. J. Gen. Physiol. 118:251-66
87. Kegel B, Braun N, Heine P, Maliszewski CR, Zimmermann H. 1997. An ectoATPase and an ecto-ATP diphosphohydrolase are expressed in rat brain. Neuropharmacology 36:1189-200
88. 2+)-apyrase. J. Biol. Chem. 271:9898-901
89. Sandoval S, Garcia L, Mancilla M, Kettlun AM, Collados L, et al. 1996. ATP-diphosphohydrolase activity in rat renal microvillar membranes and vascular tissue. Int. J. Biochem. Cell Biol. 28:591-99
90. Enjyoji K, Sevigny J, Lin Y, Frenette PS, Christie PD, et al. 1999. Targeted disruption of cd39/ATP diphosphohydrolase results in disordered hemostasis and thromboregulation. Nat. Med. 5:1010-17
91. Cunha RA, Sebastiao AM, Ribeiro JA. 1998. Inhibition by ATP of hippocampal synaptic transmission requires localized extracellular catabolism by ecto-nucleotidases into adenosine and channeling to adenosine A1 receptors. J. Neurosci. 18:1987-95
92. Vieira VP, Rocha JB, Stefanello FM, Balz D, Morsch VM, et al. 2001. Heparin and chondroitin sulfate inhibit adenine nucleotide hydrolysis in liver and kidney membrane enriched fractions. Int. J. Biochem. Cell Biol. 33:1193-201
93. Ziganshin AU, Ziganshina LE, Bodin P, Bailey D, Burnstock G. 1995. Effects of P2-purinoceptor antagonists on ecto-nucleotidase activity of guinea-pig vas deferens cultured smooth muscle cells. Biochem. Mol. Biol. Int. 36:863-69
94. Resta R, Hooker SW, Hansen KR, Laurent AB, Park JL, et al. 1993. Murine ecto-5′-nucleotidase (CD73): cDNA cloning and tissue distribution. Gene 133:171-77
95. Resta R, Thompson LF. 1997. T cell signalling through CD73. Cell Signal 9:131-39
96. Wu F, Li PL, Zou AP. 1999. Microassay of 5′-nucleotidase and adenosine deaminase activity in microdissected nephron segments. Anal. Biochem. 266:133-39
97. Siegfried G, Amiel C, Friedlander G. 1996. Inhibition of ecto-5′-nucleotidase by nitric oxide donors. Implications in renal epithelial cells. J. Biol. Chem. 271:4659-64
98. Chen YF, Li PL, Zou AP. 2001. Oxidative stress enhances the production and actions of adenosine in the kidney. Am. J. Physiol. Regulatory Integrative Comp. Physiol. 281:R1808-R16
99. Jackson EK, Dubey RK. 2001. Role of the extracellular cAMP-adenosine pathway in renal physiology. Am. J. Physiol. Renal Physiol. 281:F597-F612
100. Bankir L, Ahloulay M, Devreotes PN, Parent CA. 2002. Extracellular cAMP inhibits proximal reabsorption: Are plasma membrane cAMP receptors involved? Am. J. Physiol. Renal Physiol. 282:F376-F92
101. Jackson EK, Mi Z, Gillespie DG, Dubey RK. 1997. Metabolism of cAMP to adenosine in the renal vasculature. J. Pharmacol. Exp. Ther. 283:177-82
102. Jackson EK, Mi Z. 2000. Preglomerular microcirculation expresses the cAMP-adenosine pathway. J. Pharmacol. Exp. Ther. 295:23-28
103. Savic V, Blanchard A, Vlahovic P, Stefanovic V, Ardaillou N, et al. 1991. Cyclic adenosine monophosphate-stimulating agents induce ecto-5′- nucleotidase activity and inhibit DNA synthesis in rat cultured mesangial cells. Arch. Biochem. Biophys. 290:202-6
104. Lader AS, Xiao YF, O'Riordan CR, Prat AG, Jackson GR Jr, et al. 2000. cAMP activates an ATP-permeable pathway in neonatal rat cardiac myocytes. Am. J. Physiol. Cell Physiol. 279:C173-C87
105. Lader AS, Wang Y, Jackson GR Jr, Borkan SC, Cantiello HF. 2000. cAMP-activated anion conductance is associated with expression of CFTR in neonatal mouse cardiac myocytes. Am. J. Physiol. Cell Physiol. 278:C436-C50
106. Laamarti MA, Bell PD, Lapointe JY. 1998. Transport and regulatory properties of the apical Na-K-2Cl cotransporter of maculadensa cells. Am. J. Physiol. Renal Physiol. 215:F703-F9
107. Wilcox CS, Welch WJ, Murad F, Gross SS, Taylor G, et al. 1992. Nitric oxide synthase in macula densa regulates glomerular capillary pressure. Proc. Natl. Acad. Sci. USA 89:11993-97
108. Mundel P, Bachmann S, Bader M, Fischer A, Kummer W, et al. 1992. Expression of nitric oxide synthase in kidney macula densa cells. Kidney Int. 42:1017-19
109. Welch WJ, Wilcox CS. 1997. Tubuloglomerular feedback and macula densa-derived NO. In Nitric Oxide and the Kidney, ed. MS Goligorsky, SS Gross, pp. 216-32. New York: Chapman & Hall
110. Vallon V, Traynor T, Barajas L, Huang YG, Briggs JP, et al. 2001. Feedback control of glomerular vascular tone in neuronal nitric oxide synthase knock-out mice. J. Am. Soc. Nephrol. 12:1599-606
111. Ren YL, Garvin JL, Carretero OA. 2000. Role of macula densa nitric oxide and cGMP in the regulation of tubuloglomerular feedback. Kidney Int. 58:2053-60
112. Thorup C, Persson AE. 1994. Inhibition of locally produced nitric oxide resets tubuloglomerular feedback mechanism. Am. J. Physiol. Renal Physiol. 267:F606-F11
113. 2 system. Anal. Chem. 65:1794-99
114. Kojima H, Hirotani M, Nakatsubo N, Kikuchi K, Urano Y, et al. 2001. Bioimaging of nitric oxide with fluorescent indicators based on the rhodamine chromophore. Anal. Chem. 73:1967-73
115. 3+ and their application to cellular NO determinations. Anal. Chem. 68:3128-34
116. Tristani-Firouzi M, DeMaster EG, Quast BJ, Nelson DP, Archer SL. 1998. Utility of a nitric oxide electrode for monitoring the administration of nitric oxide in biologic systems. J. Lab. Clin. Med. 131:281-85
117. Noiri E, Peresleni T, Miller F, Goligorsky MS. 1996. In vivo targeting of inducible NO synthase with oligodeoxynucleotides protects rat kidney against ischemia. J. Clin. Invest. 97:2377-83
118. Majid DS, Omoro SA, Chin SY, Navar LG. 1998. Intrarenal nitric oxide activity and pressure natriuresis in anesthetized dogs. Hypertension 32:266-72
119. Zhang X, Cardosa L, Broderick M, Fein H, Lin J. 2000. An integrated nitric oxide sensor based on carbon fiber electrode coated with selective membranes. Electroanalysis 12:1113-17
120. Levine DZ, Iacovitti M, Burns KD, Zhang X. 2001. Real-time profiling of kidney tubular fluid nitric oxide concentrations in vivo. Am. J. Physiol. Renal Physiol. 281:F189-F94
121. Malinski T, Taha Z. 1992. Nitric oxide release from a single cell measured in situ by a porphyrinic-based microsensor. Nature 358:676-78
122. Zhang X, Kislyak Y, Lin J, Dickson A, Cardosa L, et al. 2002. Nanometer size electrode for nitric oxide and S-nitrosothiols measurement. Electrochem. Comm. 4:11-16
123. Suzuki N, Kojima H, Urano Y, Kikuchi K, Hirata Y, et al. 2002. Orthogonality of calcium concentration and ability of 4,5-diaminofluorescein to detect NO. J. Biol. Chem. 277:47-49
124. Kojima H, Nakatsubo N, Kikuchi K, Kawahara S, Kirino Y, et al. 1998. Detection and imaging of nitric oxide with novel fluorescent indicators: diaminofluoresceins. Anal. Chem. 70:2446-53
125. Levine DZ, Iacovitti M. 2002. Nitric oxide [NO] concentrations in distal tubular fluid are modulated in vivo by loop perfusion of NaCl in normal and diabetic rats. Proc. Can. Soc. Nephrol. Abstr.
126. Davis KL, Martin E, Turko IV, Murad F. 2001. Novel effects of nitric oxide. Annu. Rev. Pharmacol. Toxicol. 41:203-36
127. Kovacs G, Peti-Peterdi J, Bell PD. 2002. Interaction between NO and Na: 2Cl:K cotransport in macula densa cells. FASEB J. 16:A1174 (Abstr.)
128. Pawloski JR, Hess DT, Stamler JS. 2001. Export by red blood cells of nitric oxide bioactivity. Nature 409:622-26
129. Wilcox CS, Welch WJ. 2000. Interaction between nitric oxide and oxygen radicals in regulation of tubuloglomerular feedback. Acta Physiol. Scand. 168:119-24
130. Welch WJ, Tojo A, Wilcox CS. 2000. Roles of NO and oxygen radicals in tubuloglomerular feedback in SHR. Am. J. Physiol. Renal Physiol. 278:F769-F76
131. Chabrashvili T, Tojo A, Onozato ML, Kitiyakara C, Quinn MT, et al. 2002. Expression and cellular localization of classic NADPH oxidase subunits in the spontaneously hypertensive rat kidney. Hypertension 39:269-74
132. Thorup C, Persson AE. 1996. Impaired effect of nitric oxide synthesis inhibition on tubuloglomerular feedback in hypertensive rats. Am. J. Physiol. Renal Physiol. 271:F246-F52
133. Welch WJ, Wilcox CS. 2001. ATI receptor antagonist combats oxidative stress and restores nitric oxide signaling in the SHR. Kidney Int. 59:1257-63
134. Hostetter TH, Olson JL, Rennke HG, Venkalachalam MA, Brenner BM. 2001. Hyperfiltration in remnant nephrons: a potentially adverse response to renal ablation. J. Am. Soc. Nephrol. 12:1315-25
135. Hosletter TH, Troy JL, Brenner BM. 1981. Glomerular hemodynamics in experimental diabetes mellilus. Kidney Int. 19:410-15
136. Vallon V, Richter K, Blantz RC, Thomson S, Osswald H. 1999. Glomerular hyperfiltration in experimenlal diabetes mellitus: potential role of tubular reabsorption. J. Am. Soc. Nephrol. 10:2569-76
137. Vallon V, Blantz RC, Thomson S. 1995. Homeostatic efficiency of tubuloglomerular feedback is reduced in eslablished diabetes mellitus in rats. Am. J. Physiol. Renal Physiol. 269: F876-F83
138. Pollock CA, Lawrence JR, Field MJ. 1991. Tubular sodium handling and tubuloglomerular feedback in experimental diabetes mellitus. Am. J. Physiol. Renal Physiol. 260:F946-F52
139. Vallon V, Kirschenmann D, Wead LM, Lortie MJ, Satriano J, et al. 1997. Effect of chronic salt loading on kidney function in early and established diabetes mellitus in rats. J. Lab. Clin. Med. 130:76-82
140. Vallon V, Wead LM, Blantz RC. 1995. Renal hemodynamics and plasma and kidney angiotensin II in established diabetes mellitus in rats: effect of sodium and salt restriction. J. Am. Soc. Nephrol. 5:1761-67
141. Miller JA. 1997. Renal responses to sodium restriction in patients with early diabetes mellitus. J. Am. Soc. Nephrol. 8:749-55
142. Allen TJ, Waldron MJ, Casley D, Jerums G, Cooper ME. 1997. Salt restriction reduces hyperfiltration, renal enlargement, and albuminuria in experimental diabetes. Diabetes 46:19-24
143. Bank N, Lahorra G, Aynedjian HS, Wilkes BM. 1988. Sodium restriction corrects hyperfiltration of diabetes. Am. J. Physiol. Renal Physiol. 254:F668-F76
144. Thorup C, Ollerstam A, Persson AE, Torffvit O. 2000. Increased tubuloglomerular feedback reactivity is associated with increased NO production in the streptozotocin-diabetic rat. J. Diabetes Complications 14:46-52
145. Thomson SC, Deng A, Bao D, Satriano J, Blantz RC, et al. 2001. Ornithine decarboxylase, kidney size, and the tubular hypothesis of glomerular hyperfiltration in experimental diabetes. J. Clin. Invest. 107:217-24
146. Komers R, Lindsley JN, Oyama TT, Allison KM, Anderson S. 2000. Role of neuronal nitric oxide synthase (NOS1) in the pathogenesis of renal hemodynamic changes in diabetes. Am. J. Physiol. Renal Physiol. 279:F573-F83
147. Maree A, Peer G, Iaina A, Blum M, Wollman Y, et al. 1996. Nitric oxide in streptozotocin-induced diabetes mellitus in rats. Clin. Sci. 90:379-84
148. Mattar AL, Fujihara CK, Ribeiro MO, de Nucci G, Zatz R. 1996. Renal effects of acute and chronic nitric oxide inhibition in experimental diabetes. Nephron 74:136-43
149. Veelken R, Hilgers KF, Hartner A, Haas A, Bohmer KP, et al. 2000. Nitric oxide synthase isoforms and glomerular hyperfiltration in early diabetic nephropathy. J. Am. Soc. Nephrol. 11:71-79
150. Levine DZ, Burns KD, Iacovitti M. 2002. Nitric oxide concentrations [NO] in distal tubule fluid is modulated in vivo by loop perfusion of NaCl in normal rats. J. Am. Soc. Nephrol. 13:(Abstr.) In press
151. Reyes AA, Purkerson ML, Karl I, Klahr S. 1992. Dietary supplementation with L-arginine ameliorates the progression of renal disease in rats with subtotal nephrectomy. Am. J. Kidney Dis. 20: 168-76
152. Reyes AA, Karl IE, Kissane J, Klahr S. 1993. L-arginine administration prevents glomerular hyperfiltration and decreases proteinuria in diabetic rats. J. Am. Soc. Nephrol. 4:1039-45
153. Goligorsky MS. 2000. Endothelial cell dysfunction and nitric oxide synthase. Kidney Int. 58:1360-76
154. Ishii N, Patel KP, Lane PH, Taylor T, Bian K, et al. 2001. Nitric oxide synthesis and oxidative stress in the renal cortex of rats with diabetes mellitus. J. Am. Soc. Nephrol. 12:1630-39
155. Schnackenberg CG. 2002. Physiological and pathophysiological roles of oxygen radicals in the renal microvasculature. Am. J. Physiol. Regul. Integr. Comp. Physiol. 282:R335-R42
156. -reabsorption in surviving rat distal tubules: expression/activation of H(+)-ATPase. Am. J. Physiol. Renal Physiol. 272:F799-F808
157. Levine DZ, Iacovitti M, Harrison V. 1991. Bicarbonate secretion in vivo by rat distal tubules during alkalosis induced by dietary chloride restriction and alkali loading. J. Clin. Invest. 87:1513-18
158. Blantz RC, Peterson OW, Thomson SC. 1991. Tubuloglomerular feedback responses to acute contralateral nephrectomy. Am. J. Physiol. Renal Physiol. 260:F749-F56
159. Salmond R, Seney FJ. 1991. Reset tubuloglomerular feedback permits and sustains glomerular hyperfunction after extensive renal ablation. Am. J. Physiol. Renal Physiol. 260:F395-F401
160. Aiello S, Noris M, Todeschini M, Zappella S, Foglieni C, et al. 1997. Renal and systemic nitric oxide synthesis in rats with renal mass reduction. Kidney Int. 52:171-81
161. Roczniak A, Fryer JN, Levine DZ, Burns KD. 1999. Downregulation of neuronal nitric oxide synthase in the rat remnant kidney. J. Am. Soc. Nephrol. 10:704-13